Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA-dominant diseases.

Robert J Osborne1, Charles A Thornton

  • 1Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA.

Human Molecular Genetics
|September 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Muscle & nerve·2026
Same author

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.

Neurology·2026
Same author

An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.

The New England journal of medicine·2026
Same author

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

Communications medicine·2026
Same author

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

PloS one·2025
Same author

Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy.

bioRxiv : the preprint server for biology·2025
Same journal

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026
Same journal

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026
Same journal

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Human molecular genetics·2026
Same journal

Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.

Human molecular genetics·2026
Same journal

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss.

Human molecular genetics·2026
Same journal

Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.

Human molecular genetics·2026
See all related articles

Mutations in non-protein-coding regions can cause toxic non-coding RNA, leading to degenerative diseases. This RNA interferes with protein binding and alternative splicing regulation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • Mutations in non-protein-coding regions are increasingly recognized as disease-causing.
  • Non-coding RNA can exert toxic gain-of-function effects.
  • These effects are linked to nuclear inclusions and late-onset neurodegenerative and myodegenerative disorders.

Purpose of the Study:

  • To review recent advances in understanding the pathophysiology of RNA-dominant diseases.
  • To highlight the role of toxic non-coding RNA in disease.
  • To discuss the mechanisms by which toxic RNA causes cellular dysfunction.

Main Methods:

  • Literature review of studies on RNA-dominant diseases.
  • Analysis of molecular mechanisms underlying toxic RNA function.

Related Experiment Videos

  • Case studies, focusing on myotonic dystrophy as a model.

    • Main Results:

    • Toxic non-coding RNA expression correlates with nuclear inclusions and tissue degeneration.
    • In myotonic dystrophy, toxic RNA sequesters RNA-binding proteins.
    • Compromised regulation of alternative splicing is a key pathogenic mechanism.

    Conclusions:

    • RNA-dominant diseases represent a significant class of genetic disorders.
    • Understanding the pathophysiology of toxic RNA is crucial for developing therapeutic strategies.
    • Further research into non-coding RNA function and dysfunction is warranted.